Leukemia Tissue Bank

白血病组织库

基本信息

  • 批准号:
    7630214
  • 负责人:
  • 金额:
    $ 5.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The ability to successfully translate basic research in leukemia to the clinical setting, as well as to better understand the relevance of observed clinical phenomena through laboratory-based research, is greatly facilitated by the availability of an extensive repository of tissue samples, with accompanying complete pathologic and clinical data, procured from leukemia patients. The OSUCCC Leukemia Tissue Bank Shared Resource (LTBSR), separate and distinct from the CALGB Leukemia Tissue Bank, is a shared resource established in 1997 with over 4,500 patient samples procured from 762 consented leukemia patients at OSU. The infrastructure of the OSUCCC LTBSR is well-established and is directly under our leadership. Specifically we have a large leukemia tissue repository, including both leukemic tissue and normal tissue germ line DNA, accompanied in all cases with complete pathologic, cytogenetic and clinical data for ready correlation of clinical and biological results. In addition, all the essentials of effective leukemia tissue bank management, including the activities of tissue collection, quality control of specimens, tissue storage, procurement of initial and follow-up samples and their pathology and clinical information, data entry and database management, and patient consent and confidentiality are very well developed. Furthermore, the procedures for prioritizing and distributing tissue to a large base of investigators within the OUCCC are effectively in place. Finally, our success in managing this large leukemia tissue resource can be seen in the documented sample collection for and sample distribution to all leukemia researchers within the CCC and 28 publications where the OSUCCC LTBSR has played a significant role. Against this background, we believe that this Shared Resource will function well in the support of the research mission of the OSUCCC in )roducing high-quality basic and clinical research in hematological malignancy. Currently the OSUCCC _TBSR is funded solely with OSUCCC/institutional support. The Specific Aims of this Shared Resource are, therefore, to: 1) Continue to provide a central collection, processing and a state-of-the-art repository for samples collected from leukemia patients treated on OSU protocols, and 2) Provide materials from the LTBSR to interested investigators within OSUCCC, as well as to outside interested investigators involved in collaborative studies with OSU, who examine relevant cellular and molecular properties of leukemia.
成功地将白血病基础研究转化为临床环境的能力,以及更好地 通过实验室研究了解观察到的临床现象的相关性, 通过提供广泛的组织样本库,以及随附的完整的 从白血病患者中获得的病理和临床数据。OSUCCC白血病组织库 共享资源(LTBSR),独立于CALGB白血病组织库,是一个共享的 1997年建立的资源,从762例同意的白血病患者中采购了4,500多份患者样本 患者在OSU OSUCCC LTBSR的基础设施完善,直接隶属于我们的 领导具体来说,我们有一个大型的白血病组织库,包括白血病组织和 所有病例均伴有完整的病理、细胞遗传学和临床表现, 数据用于临床和生物学结果的快速关联。此外,有效治疗白血病的所有要素 组织库管理,包括组织采集、标本质量控制、组织 初始和随访样本及其病理学和临床信息的储存、获取、数据录入 和数据库管理,以及患者同意和保密性都得到了很好的发展。此外,委员会认为, OUCCC内对大量研究者进行组织优先排序和分配的程序如下 有效到位。最后,我们在管理这种大型白血病组织资源方面的成功可以从以下方面看到: 记录CCC内所有白血病研究人员的样本采集和样本分发, OSUCCC LTBSR发挥了重要作用的出版物。在此背景下,我们认为 这一共享资源将在支持OSUCCC的研究使命方面发挥良好作用, )开展高质量的恶性血液病基础和临床研究。目前,OSUCCC _TBSR仅由OSUCCC/机构支持资助。本共享资源的具体目标是, 1)继续提供中央收集、处理和最先进的储存库, 从接受OSU方案治疗的白血病患者中收集的样本,以及2)提供来自 向OSUCCC内部的相关研究者以及参与以下研究的外部相关研究者提供LTBSR 与俄勒冈州立大学的合作研究,他们检查白血病的相关细胞和分子特性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sherif S Farag其他文献

The emin Vitro/em and emIn Vivo/em Effects of DPP-4 Inhibition with Sitagliptin, Alone and in Combination with Bortezomib, on T Cell Activation: Rationale for GvHD Prevention
  • DOI:
    10.1182/blood-2022-163679
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Shuhong Zhang;Xingkui Xue;Maggie Granatir;George E. Sandusky;Sheng Liu;Jun Wan;Xiaoling Xuei;Yunlong Liu;Anthony L. Sinn;Karen E. Pollok;Sherif S Farag
  • 通讯作者:
    Sherif S Farag
The <em>in Vitro</em> and <em>In Vivo</em> Effects of DPP-4 Inhibition with Sitagliptin, Alone and in Combination with Bortezomib, on T Cell Activation: Rationale for GvHD Prevention
  • DOI:
    10.1182/blood-2022-163679
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Shuhong Zhang;Xingkui Xue;Maggie Granatir;George E. Sandusky;Sheng Liu;Jun Wan;Xiaoling Xuei;Yunlong Liu;Anthony L. Sinn;Karen E. Pollok;Sherif S Farag
  • 通讯作者:
    Sherif S Farag
Mgta-117, an Anti-CD117 Antibody-Drug Conjugated with Amanitin, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics and Pharmacodynamics Initial Findings from a Phase 1/2 Study
  • DOI:
    10.1182/blood-2022-162406
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Peter Westervelt;Partow Kebriaei;Mark Juckett;Andrew S. Artz;Onyee Chan;Philip L. McCarthy;Sherif S Farag;Anurag K. Singh;Eytan Stein;Jeffrey Humphrey;William Baeder;Ji Hyun Lee;Alison Occhiuti;Jeanie Tang;David Santos;Kirk Bertelsen;Balaji Mahender;Nicole Henry;Shawn Rose
  • 通讯作者:
    Shawn Rose
The Pre-Existing T Cell Landscape Is Associated with Response to High Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
  • DOI:
    10.1182/blood-2022-167619
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Mohammad Issam Abu Zaid;Parvathi Sudha;Travis S Johnson;Vivek S. Chopra;Cedric E. Dos Santos;Michael Nixon;Attaya Suvannasankha;Sherif S Farag;Kelvin P. Lee;Rafat Abonour;Brian A. Walker
  • 通讯作者:
    Brian A. Walker

Sherif S Farag的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sherif S Farag', 18)}}的其他基金

Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
抑制 PGE2 对自体外周血干细胞动员的影响
  • 批准号:
    9261489
  • 财政年份:
    2014
  • 资助金额:
    $ 5.96万
  • 项目类别:
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
抑制 PGE2 对自体外周血干细胞动员的影响
  • 批准号:
    8633799
  • 财政年份:
    2014
  • 资助金额:
    $ 5.96万
  • 项目类别:
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
抑制 PGE2 对自体外周血干细胞动员的影响
  • 批准号:
    9052158
  • 财政年份:
    2014
  • 资助金额:
    $ 5.96万
  • 项目类别:
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
EMND-2076 对多发性骨髓瘤的多激酶靶点抑制
  • 批准号:
    8013948
  • 财政年份:
    2010
  • 资助金额:
    $ 5.96万
  • 项目类别:
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
EMND-2076 对多发性骨髓瘤的多激酶靶点抑制
  • 批准号:
    7787139
  • 财政年份:
    2010
  • 资助金额:
    $ 5.96万
  • 项目类别:
Pathology
病理
  • 批准号:
    6986013
  • 财政年份:
    2005
  • 资助金额:
    $ 5.96万
  • 项目类别:
Leukemia Tissue Bank
白血病组织库
  • 批准号:
    7613092
  • 财政年份:
    2005
  • 资助金额:
    $ 5.96万
  • 项目类别:
QMS Technology to Deplete T Cell Alloreactivity
QMS 技术消除 T 细胞同种异体反应性
  • 批准号:
    6891062
  • 财政年份:
    2004
  • 资助金额:
    $ 5.96万
  • 项目类别:
mTOR Inhibition as a Therapeutic Target in Myeloma
mTOR 抑制作为骨髓瘤的治疗靶点
  • 批准号:
    6940691
  • 财政年份:
    2004
  • 资助金额:
    $ 5.96万
  • 项目类别:
mTOR Inhibition as a Therapeutic Target in Myeloma
mTOR 抑制作为骨髓瘤的治疗靶点
  • 批准号:
    6887130
  • 财政年份:
    2004
  • 资助金额:
    $ 5.96万
  • 项目类别:

相似海外基金

AI-powered digital healthcare platform that delivers health benefits to Bengali speakers in the UK through voice-driven remote medical triaging, appointment booking and self-care at home.
由人工智能驱动的数字医疗平台,通过语音驱动的远程医疗分类、预约和在家自我护理,为英国的孟加拉语使用者提供健康益处。
  • 批准号:
    10043942
  • 财政年份:
    2022
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Grant for R&D
NHS Appointment Recovery Project
NHS 预约恢复项目
  • 批准号:
    62930
  • 财政年份:
    2020
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Feasibility Studies
An Innovative, Automated, Machine Learning Appointment, Logistics and Communication Platform for Mobile Service Provider SMEs that can incorporate
为移动服务提供商中小企业提供创新、自动化、机器学习预约、物流和通信平台,可将
  • 批准号:
    86195
  • 财政年份:
    2020
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Collaborative R&D
Factors Promoting and Inhibiting the Appointment of Women in the Public Sector
促进和抑制妇女在公共部门任职的因素
  • 批准号:
    20H01456
  • 财政年份:
    2020
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Primary Care Online Appointment Scheduling Platform for Emergency Departments: Improving the Care Transition between Emergency and Primary Care
急诊科初级保健在线预约安排平台:改善急诊和初级保健之间的护理过渡
  • 批准号:
    382187
  • 财政年份:
    2018
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Operating Grants
Appointment of Supreme Court Justices and Formation of Judicial Precedents
最高法院法官的任命和判例的形成
  • 批准号:
    18K01395
  • 财政年份:
    2018
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantitative network analysis of appointment diaries
预约日记的定量网络分析
  • 批准号:
    ES/R009236/1
  • 财政年份:
    2018
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Research Grant
A Study on the Process of Appointment of Principal by Physical Education Teachers and Formation of Management Competence
体育教师校长聘任过程与管理能力形成研究
  • 批准号:
    16K16538
  • 财政年份:
    2016
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Reconstruction of the history of Japanese education through historical clarification of the transition between education at "daigaku" and appointment of government officials in ancient Japan
通过历史澄清古代日本“大学”教育与政府官员任用之间的转变,重建日本教育史
  • 批准号:
    15K17374
  • 财政年份:
    2015
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Appointment Provisioning/Booking Platform
预约提供/预订平台
  • 批准号:
    486943-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 5.96万
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了